Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Esperion Theraptc (NQ: ESPR )

25.93 USD +0.48 (+1.89%)
Official Closing Price Updated: 7:39 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Esperion Theraptc

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Esperion Therapeutics to Host Second Annual Analyst and Investor Day
From Marketwired News Releases
Critical Alerts For FireEye, Ariad Pharmaceuticals, ACADIA Pharmaceuticals, Esperion Therapeutics and Humana Released By InvestorsObserver
From PR Newswire
Esperion Therapeutics Announces Removal of 240 mg Partial Clinical Hold for ETC-1002
From Marketwired News Releases
Critical Alerts For FireEye, Petrobras, Impac Mortgage Holdings Inc, Esperion Therapeutics and Palo Alto Networks Released By InvestorsObserver
From PR Newswire
Critical Alerts For Esperion Therapeutics, Ambarella, Horizon Pharma, Universal Display Corporation and Vale Released By InvestorsObserver
From PR Newswire
Esperion Therapeutics to Present at the JMP Securities Life Science Conference
Presentation and Webcast on Tuesday, June 23, 2015 at 4:30 P.M. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics Announces the Appointment of Scott Braunstein, M.D. to Board of Directors
From Marketwired News Releases
Critical Alerts For Juno Therapeutics Inc, Broadcom, Eli Lilly, Esperion Therapeutics and World Wrestling Entertainment Released By InvestorsObserver
From PR Newswire
Critical Alerts For Under Armour, Cal-Maine Foods, Opko Health, Microsoft and Esperion Therapeutics Released By InvestorsObserver
From PR Newswire
Esperion Therapeutics to Present at the UBS Global Healthcare Conference
Presentation and Webcast on Monday, May 18, 2015 at 9:30 A.M. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports First Quarter 2015 Financial Results
Conference Call and Webcast Today, May 7, 2015 at 4:30 p.m. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics to Present at Bank of America Merrill Lynch 2015 Healthcare Conference
Presentation on Tuesday, May 12, 2015 at 11:20 a.m. Pacific Time/2:20 p.m. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics to Provide First Quarter 2015 Results
Conference Call and Webcast on Thursday, May 7, 2015 at 4:30 p.m. Eastern Time 
From Marketwired News Releases
Critical Alerts For BlackBerry, Hasbro, Esperion Therapeutics, Chesapeake Energy and OmniVision Released By InvestorsObserver
From PR Newswire
Esperion Therapeutics to Present at 14th Annual Needham Healthcare Conference
Presentation and Webcast on Tuesday, April 14, 2015 at 1:40 p.m. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock
From Marketwired News Releases
StockRing Has Just 5 Biotech Stocks to Buy Now
From ReleaseWire - Latest Press Releases
Esperion Therapeutics Prices Public Offering of Common Stock
From Marketwired News Releases
Critical Alerts For Rite Aid, Esperion Therapeutics, Vivint Solar Inc, Priceline and PepsiCo Released By InvestorsObserver
From PR Newswire
Esperion Therapeutics Announces Proposed Public Offering of Common Stock
From Marketwired News Releases
Esperion Therapeutics Announces Positive Top-Line Phase 2b Results for ETC-1002 Added to Stable Statin Therapy in Patients With Hypercholesterolemia
ETC-1002-009 Study Meets Primary Endpoint 
From Marketwired News Releases
Esperion Therapeutics to Present at Bank of America Merrill Lynch Smid Cap and BioCentury Future Leaders in the Biotech Industry Conferences
From Marketwired News Releases
ETC-1002-008 Phase 2b Results to be Presented at the American College of Cardiology 64th Annual Scientific Session
Company to Host Webcast on Saturday, March 14, 2015 at 7:00 p.m. Pacific Time/10:00 p.m. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Fourth Quarter and Full Year 2014 Financial Results
Conference Call and Webcast Today, Thursday, March 5, 2015, at 4:30 p.m. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics to Present at Barclays Global Healthcare Conference
Presentation and Webcast on Tuesday, March 10, 2015 at 3:20 p.m. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics to Provide Fourth Quarter and Full Year ETC-1002 Program Updates and Financial Results
Conference Call and Webcast on Thursday, March 5, 2015 at 4:30 p.m. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics Announces Removal of PPAR Partial Clinical Hold for ETC-1002
Conference Call and Webcast on Monday, February 2, 2015 at 4:30 p.m. Eastern Time 
From Marketwired News Releases
Esperion Therapeutics to Present at 33rd Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
CORRECTION - Annual Changes to the NASDAQ Biotechnology Index
From GlobeNewswire News Releases
Esperion Therapeutics to Present at Stifel 2014 Healthcare Conference
From Business Wire News Releases
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.